Who are Progyny's decision-makers?
Progyny's leadership team is anchored by Pete Anevski. Enterprise purchases usually require sponsorship from the business owner plus finance, procurement, legal, security, compliance, and IT or data leaders.
- CEO
- Pete Anevski
- CFO/key exec
- David Schlanger
- Founded
- 2008
- Employees
- 700+
- HQ
- New York, NY
- Notable
- Nasdaq: PGNY
- Pete AnevskiChief Executive OfficerCEO since 2023Leads employer-benefits growth and operating execution.
- David SchlangerExecutive ChairmanExecutive chairmanFormer CEO and board leader.
- Mark LivingstonChief Financial OfficerCFOOwns finance and investor communications.
- Georgia WitkinChief Medical OfficerClinical leaderGuides clinical and member support programs.
Who leads Progyny?
Pete Anevski serves as Chief Executive Officer; David Schlanger serves as Executive Chairman; Mark Livingston serves as Chief Financial Officer; Georgia Witkin serves as Chief Medical Officer. The team combines category, finance, commercial, clinical, technical, and operations ownership.
For account mapping, treat the named leaders as executive context rather than the only buying path. Most projects will start with a functional sponsor and move upward only after a clear business case exists.
Who actually makes buying decisions at Progyny?
Budget ownership depends on the project: commercial leaders own revenue tools, clinical and product leaders own workflow and evidence needs, technology leaders own platform and security fit, and finance or procurement controls approval thresholds.
Because Progyny operates in healthcare or life sciences, legal, privacy, compliance, quality, and information-security review can be as important as the economic buyer.
How is Progyny organized as it scales?
Progyny should be approached as a public-company operating organization with business units, functional teams, and governance layers. The company has 700+ employees and operates from New York, NY with additional offices or distributed teams.
Good account plans identify the operational metric at stake, the system of record involved, the compliance requirement, the implementation owner, and the executive sponsor before asking for a broad enterprise commitment.
As of June 2026.Sources:Progyny websiteProgyny quarterly results
Progyny — frequently asked questions
